111.9
[1]. Aaron M Gruver, et al. Immunohistochemical application of a highly sensitive and specific murine monoclonal antibody recognising the extracellular domain of the human hepatocyte growth factor receptor (MET). Histopathology. 2014 Dec;65(6):879-96.
[2]. Faik G Uzunoglu, et al. Loss of 4q21.2-22.1 is a prognostic marker for disease free and overall survival in non-small cell lung cancer. PLoS One. 2014 Dec 11;9(12):e1115.
[]. Joanna M Woodcock, et al. Destabilisation of dimeric 14-- proteins as a novel approach to anti-cancer therapeutics. Oncotarget. 2015 Jun 10;6(16):14522-6.
[4]. Laura H Eaton, et al. Skin sensitization induced Langerhans cell mobilization: variable requirements for tumour necrosis factor-α. Immunology. 2015 Jan;144(1):19-48.
[5]. S Busch, et al. TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer. Oncogene. 2015 Jan 2;4(1):27-8.
H02-H15-H19-H5
P261-P264-P270-P271-P280-P02+P52-P04+P40-P05+P51+P8-P0-P62+P64-P40+P2-P405-P501